340 related articles for article (PubMed ID: 32473611)
61. Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer.
Kim M; Lu F; Zhang Y
Cell Rep; 2016 Sep; 17(1):275-288. PubMed ID: 27681437
[TBL] [Abstract][Full Text] [Related]
62. Adenomyosis pathogenesis: insights from next-generation sequencing.
Bulun SE; Yildiz S; Adli M; Wei JJ
Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
[TBL] [Abstract][Full Text] [Related]
63. Mutation and methylation profiles of ectopic and eutopic endometrial tissues.
Li L; Antero MF; Zhang M; Chu T; Seckin T; Ayhan A; Pisanic T; Wang TL; Cope L; Segars J; Shih IM
J Pathol; 2021 Dec; 255(4):387-398. PubMed ID: 34396532
[TBL] [Abstract][Full Text] [Related]
64. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
65. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
66. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
Kajihara H; Yamada Y; Shigetomi H; Higashiura Y; Kobayashi H
Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
[TBL] [Abstract][Full Text] [Related]
67. A rare case of the coexistence of ovarian clear cell carcinoma, mucinous cystadenoma, and endometriosis in the same ovary.
Shang HS; Chao TK; Wu GZ; Yu CP
Eur J Gynaecol Oncol; 2011; 32(6):677-9. PubMed ID: 22335035
[TBL] [Abstract][Full Text] [Related]
68. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
69. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.
Maeda D; Shih IeM
Adv Anat Pathol; 2013 Jan; 20(1):45-52. PubMed ID: 23232571
[TBL] [Abstract][Full Text] [Related]
70. [Early malignant changes in ovarian epithelium--the relationship between histology and molecular biological change].
Ichikawa Y
Hum Cell; 2000 Mar; 13(1):3-6. PubMed ID: 10937341
[No Abstract] [Full Text] [Related]
71. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
72. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
73. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
[TBL] [Abstract][Full Text] [Related]
74. Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes.
Koppolu A; Maksym RB; Paskal W; Machnicki M; Rak B; Pępek M; Garbicz F; Pełka K; Kuśmierczyk Z; Jacko J; Rydzanicz M; Banach-Orłowska M; Stokłosa T; Płoski R; Malejczyk J; Włodarski PK
Cells; 2021 Mar; 10(4):. PubMed ID: 33805315
[TBL] [Abstract][Full Text] [Related]
75. Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.
Körner M; Burckhardt E; Mazzucchelli L
Mod Pathol; 2006 Dec; 19(12):1615-23. PubMed ID: 16980942
[TBL] [Abstract][Full Text] [Related]
76. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
77. Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.
Bulun SE; Wan Y; Matei D
Endocrinology; 2019 Mar; 160(3):626-638. PubMed ID: 30657901
[TBL] [Abstract][Full Text] [Related]
78. The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions.
Garavaglia E; Sigismondi C; Ferrari S; Candiani M
Med Hypotheses; 2018 Jan; 110():80-82. PubMed ID: 29317075
[TBL] [Abstract][Full Text] [Related]
79. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
80. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.
Murakami R; Matsumura N; Brown JB; Higasa K; Tsutsumi T; Kamada M; Abou-Taleb H; Hosoe Y; Kitamura S; Yamaguchi K; Abiko K; Hamanishi J; Baba T; Koshiyama M; Okuno Y; Yamada R; Matsuda F; Konishi I; Mandai M
Am J Pathol; 2017 Oct; 187(10):2246-2258. PubMed ID: 28888422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
